Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
B

Britannia Life Sciences Inc
F:L020

Watchlist Manager
Britannia Life Sciences Inc
F:L020
Watchlist
Price: 0.0475 EUR 1.06%
Market Cap: €19.4m
Write Note Create Alert Ask AI

Gross Margin

55.6%
Current
Declining
by 5.6%
vs 3-y average of 61.3%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
55.6%
=
Gross Profit
CA$1.2m
/
Revenue
CA$2.1m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
55.6%
=
Gross Profit
€1.2m
/
Revenue
CA$2.1m

Peer Comparison

Market Distribution

Higher than 75% of companies in Canada
Percentile
75th
Based on 4 108 companies
75th percentile
55.6%
Low
-10 058.3% — 20.4%
Typical Range
20.4% — 50.5%
High
50.5% — 717.4%
Distribution Statistics
Canada
Min -10 058.3%
30th Percentile 20.4%
Median 33.6%
70th Percentile 50.5%
Max 717.4%

Other Profitability Ratios

Britannia Life Sciences Inc
Glance View

Market Cap
19.4m EUR
Industry
N/A

Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

L020 Intrinsic Value
0.0245 EUR
Overvaluation 49%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

Summary
L020 intrinsic value, competitors valuation, and company profile.
DCF Valuation
L020 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
L020 stock valuation using valuation multiples.
Wall Street Estimates
L020 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
L020 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
55.6%
=
Gross Profit
CA$1.2m
/
Revenue
CA$2.1m
What is Britannia Life Sciences Inc's current Gross Margin?

The current Gross Margin for Britannia Life Sciences Inc is 55.6%, which is below its 3-year median of 61.3%.

How has Gross Margin changed over time?

Over the last 3 years, Britannia Life Sciences Inc’s Gross Margin has decreased from 69.7% to 55.6%. During this period, it reached a low of 26.6% on Mar 31, 2024 and a high of 73.2% on Jun 30, 2023.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.